Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity of Fractional Dose of the Bivalent and Nonavalent Intradermal HPV Vaccines.

NCT04235257 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT04235257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04235257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity of Fractional Dose of the Bivalent and Nonavalent Intradermal HPV Vaccines.
Lead sponsor
University of Washington
Phase
Phase 4
Overall status
Active, not recruiting
Start date
November 1, 2020
Completion date
December 31, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hpv infection, hpv vaccine